Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (941-950 of 1,132) with videos related to

Pageof 114
Sort By:
Human Pathology|December 1, 2001
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinomaN Rioux-Leclercq, J I Epstein, J Y Bansard, et al.
The New England Journal of Medicine|September 6, 1990
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trialM D Rifkin, E A Zerhouni, C A Gatsonis, et al.
Biochemical and Biophysical Research Communications|January 14, 1994
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancerM P Schoenberg, J M Hakimi, S Wang, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
Histopathology|November 2, 2016
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelMuhammad T Idrees, Thomas M Ulbright, Esther Oliva, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Human Pathology|October 20, 2004
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinomaNathalie Rioux-Leclercq, Jean-Guy Delcros, Jean-Yves Bansard, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
The American Journal of Surgical Pathology|January 5, 2021
Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 CasesPedram Argani, Derrick W Q Lian, Abbas Agaimy, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Pageof 114

Showing results (941-950 of 1,132) with videos related to

Sort By:
Pageof 114
Human Pathology|December 1, 2001
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinomaN Rioux-Leclercq, J I Epstein, J Y Bansard, et al.
The New England Journal of Medicine|September 6, 1990
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trialM D Rifkin, E A Zerhouni, C A Gatsonis, et al.
Biochemical and Biophysical Research Communications|January 14, 1994
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancerM P Schoenberg, J M Hakimi, S Wang, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
Histopathology|November 2, 2016
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelMuhammad T Idrees, Thomas M Ulbright, Esther Oliva, et al.
European Urology|October 25, 2012
Contemporary grading for prostate cancer: implications for patient careFadi Brimo, Rodolfo Montironi, Lars Egevad, et al.
Human Pathology|October 20, 2004
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinomaNathalie Rioux-Leclercq, Jean-Guy Delcros, Jean-Yves Bansard, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
The American Journal of Surgical Pathology|January 5, 2021
Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 CasesPedram Argani, Derrick W Q Lian, Abbas Agaimy, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Pageof 114